Arkolith/Insider Trading/CGON/Form 4

Kuan Arthur

Chief Executive Officer, DirectorCG Oncology, Inc. (CGON) · full profile →Form 4 · filed Mar 13, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 12, 2026Tax withholding(F)2K$60.15$111K199K
Mar 12, 2026Option exercise(M)65K$1.72$111K201K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 12, 2026Option exercise(M)65K—$00

Transaction Codes

F
Shares withheld for taxes
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002007101-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML